Welcome to our dedicated page for The Beauty Health Company news (Ticker: SKIN), a resource for investors and traders seeking the latest updates and insights on The Beauty Health Company stock.
The Beauty Health Company (SKIN), innovator of Hydrafacial systems and advanced aesthetic technologies since 1997, provides this centralized hub for investors and industry professionals. Our news collection offers immediate access to verified corporate developments, combining regulatory filings with market analysis for complete transparency.
This resource serves as your primary source for tracking earnings announcements, product innovations, and strategic partnerships that shape the medical aesthetics sector. Users benefit from chronological organization of press releases alongside third-party analyses, maintaining balanced perspectives on company milestones.
Content spans critical updates including FDA clearances, international expansion efforts, and clinical study results. Each entry is vetted for relevance to investor priorities and industry trends, with particular emphasis on the company's serum-based technology advancements.
Bookmark this page for real-time updates on SKIN's market movements and professional-grade insights into the $18B global aesthetics industry. Cross-reference our archive with SEC filings using provided document identifiers for complete due diligence capabilities.
The Beauty Health Company (NASDAQ:SKIN) has completed the redemption of all outstanding public warrants from its initial public offering. As of the Redemption Date, November 3, 2021, approximately 99.5% of the public warrants were exercised. This resulted in total cash proceeds of $185.4 million, with 16,123,235 warrants exercised for cash and 74,104 on a cashless basis. The public warrants were subsequently delisted from the Nasdaq. The company's common stock continues to trade under the ticker symbol 'SKIN'.
The Beauty Health Company (NASDAQ:SKIN) will announce its third quarter 2021 financial results after the market closes on November 9, 2021. A conference call is scheduled for 4:30 p.m. Eastern Time on the same day to discuss these results. Interested participants can join the call by dialing (877) 407-9208 for domestic calls or 1 (201) 493-6784 for international calls, using conference ID 13723615. A live audio webcast will also be available for access.
The Beauty Health Company (NASDAQ:SKIN) announced a redemption of all outstanding Public Warrants for its Class A common stock at a price of $0.10 per warrant, effective November 3, 2021. This decision follows the conditions of the Warrant Agreement, which allows redemption if the stock trades above $10.00 for 20 of the 30 days prior to notice. Holders can exercise warrants until 5:00 p.m. New York City time on the Redemption Date. Unexercised warrants will be void after the Redemption Date. The Company has made no recommendations regarding the exercise of these warrants.
HydraFacial (NASDAQ:SKIN) has partnered with Epicutis to introduce the Neck & Décolleté Booster, a professional skincare product aimed at revitalizing the neckline. Combining advanced medical technology with spa therapies, HydraFacial offers personalized skin solutions using patented Vortex-Fusion® technology. The new booster is clinically proven to reduce fine lines and enhance hydration. CEO Clint Carnell stated this collaboration expands their treatment offerings, enhancing customer experience with scientifically backed ingredients.
The Beauty Health Company (NASDAQ:SKIN) announced the participation of CEO Clint Carnell and CFO Liyuan Woo in several upcoming virtual investor conferences. These include the Cowen 2nd Annual Health, Wellness & Beauty Summit on September 13, 2021, Raymond James Virtual Consumer Conference on September 14, 2021, and the Jefferies Fitness & Wellness Summit on September 15, 2021. The presentations will be available on the Company’s investor relations website and archived for later viewing.
The Beauty Health Company (NASDAQ:SKIN) announced the pricing of $650 million in 1.25% convertible senior notes due 2026. This offering increased from a previously announced $400 million. The notes are set to settle on September 14, 2021, and will accrue interest semi-annually. The initial conversion rate is set at 31.4859 shares per $1,000 principal amount, representing a conversion price of approximately $31.76 per share, a 32.5% premium over the last reported price on September 9, 2021. Net proceeds are estimated at $631.5 million, intended for future acquisitions and working capital.
The Beauty Health Company (NASDAQ:SKIN) announced a proposed private offering of $400 million in convertible senior notes due 2026, potentially raising up to $60 million more. The notes, which will mature on October 1, 2026, are unsecured and will bear interest payable semi-annually. Proceeds will support capped call transactions, future acquisitions, working capital, and general corporate purposes. The offering targets qualified institutional buyers and is subject to market conditions. Forward-looking statements caution about risks affecting completion and terms of the offering.
The Beauty Health Company (NASDAQ: SKIN) has appointed Indra Pamamull as President of APAC and promoted Mingo Ku to Chief Commercial Officer for the APAC region. Pamamull brings over 20 years of experience in beauty and has a proven track record in international sales growth, having previously worked with Estee Lauder and LVMH. Ku, who has been with BeautyHealth since 2018, doubled sales year-over-year in APAC. These strategic appointments aim to enhance BeautyHealth's presence and growth in the rapidly expanding APAC beauty market.
Beauty Health Company (NASDAQ:SKIN) reported exceptional second-quarter results for 2021, with net sales of $66.5 million, a 371.2% increase year-over-year. Delivery Systems and Consumables net sales reached $34.9 million and $31.6 million, respectively. Adjusted EBITDA rose to $11.4 million, up from a loss of $1.1 million in Q2 2020. The company raised its 2021 sales guidance to $230-$240 million, reflecting strong trends post-COVID-19. However, a net loss of $139.4 million was reported due to one-time expenses and changes in liability values.
FAQ
What is the current stock price of The Beauty Health Company (SKIN)?
What is the market cap of The Beauty Health Company (SKIN)?
